|Articles|September 1, 2016
- BioPharm International-09-01-2016
- Volume 29
- Issue 9
BioPharm International, September 2016 Issue (PDF)
Click the title above to open the BioPharm International September 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 9 years ago
Parenteral Advisory: Outmoded Fill/Finish Technologyover 9 years ago
Analyzer Automates Cell-Culture Chemistry Analysisover 9 years ago
Data Logger Provides Ultra-Low Temperature Readingsover 9 years ago
Manufacturing and Distribution Boundaries Blurover 9 years ago
Modeling Bioreactor Performanceover 9 years ago
Implementing a Dual Approach to Protein Characterizationover 9 years ago
Efforts Accelerate to Streamline Postapproval Change ProcessNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
New Draft Guidance Highlights FDA Push Toward Human-Relevant Safety Models
2
Implementing Automation and Flexible Design for Allogeneic Manufacturing
3
Regulatory Uncertainty Surfaces as FDA Blames COVID Vaccines for 10 Child Deaths
4
Neurimmune and AstraZeneca Expand Efforts to Accelerate Fibril-Depleting Therapies
5
